Cargando…
Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention
For over three decades, HIV infection has had a tremendous impact on the lives of individuals and public health. Microbicides and vaccines studies have shown that immune activation at the genital tract is a risk factor for HIV infection. Furthermore, lower level of immune activation, or what we call...
Autores principales: | Lajoie, Julie, Mwangi, Lucy, Fowke, Keith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594430/ https://www.ncbi.nlm.nih.gov/pubmed/28893304 http://dx.doi.org/10.1186/s12981-017-0166-7 |
Ejemplares similares
-
Using safe, affordable and accessible non‐steroidal anti‐inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract
por: Lajoie, Julie, et al.
Publicado: (2018) -
Low-Dose Acetylsalicylic Acid Reduces T Cell Immune Activation: Potential Implications for HIV Prevention
por: Lajoie, Julie, et al.
Publicado: (2021) -
High Level of Soluble HLA-G in the Female Genital Tract of Beninese Commercial Sex Workers Is Associated with HIV-1 Infection
por: Thibodeau, Valérie, et al.
Publicado: (2011) -
Neutrophil extracellular traps prevent HIV infection in the female genital tract
por: Barr, Fiona D., et al.
Publicado: (2018) -
The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women
por: Abdool Karim, Salim S, et al.
Publicado: (2019)